Twist Bioscience (TWST) HR SVP sells 1,133 shares in tax withholding trade
Rhea-AI Filing Summary
On August 3, 2026, Paula Green, SVP of Human Resources at Twist Bioscience Corp, sold 1,133 shares of common stock at an average price of $85.3212 per share.
A footnote states these shares were sold under a mandated "sell to cover" arrangement to satisfy tax withholding on vesting Restricted Stock Units and did not represent discretionary trades. Following the sale, she directly holds 119,281 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,133 shares
Net Sell
1 txn
Insider
Green Paula
Role
SVP of Human Resources
Sold
1,133 shs ($97K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 1,133 | $85.3212 | $97K |
Holdings After Transaction:
Common Stock — 119,281 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Key Figures
Shares sold: 1,133 shares
Average sale price: $85.3212 per share
Shares held after transaction: 119,281 shares
3 metrics
Shares sold
1,133 shares
Common stock sold on 2026-08-03 in a tax-related transaction
Average sale price
$85.3212 per share
Price for the 1,133 shares of common stock sold on 2026-08-03
Shares held after transaction
119,281 shares
Directly owned common shares following the August 3, 2026 sale
Key Terms
Restricted Stock Units, sell to cover, equity incentive plans, tax withholding obligations
4 terms
Restricted Stock Units financial
"tax withholding obligations in connection with the vesting of Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"funded by a "sell to cover" transaction and do not represent discretionary trades"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
equity incentive plans financial
"mandated by the Issuer's election under its equity incentive plans to require"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
tax withholding obligations financial
"shares required to be sold by the Reporting Person to cover tax withholding obligations"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Twist Bioscience (TWST) report for Paula Green?
Twist Bioscience reported that Paula Green, SVP of Human Resources, sold 1,133 shares of common stock at $85.3212 per share on August 3, 2026. The sale was tied to tax withholding on vesting Restricted Stock Units under a mandated "sell to cover" arrangement.
Is Paula Green’s Twist Bioscience (TWST) sale under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox is not marked, and the footnote instead describes the sale as a mandatory "sell to cover" tax-withholding transaction. The filing characterizes these sales as required by the company’s equity incentive plans, rather than discretionary planned trading.